BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,872 | -64.7% | 11,412 | -7.0% | 0.00% | – |
| Q2 2023 | $81,685 | -63.8% | 12,265 | +1.3% | 0.00% | -100.0% |
| Q1 2023 | $225,842 | -6.0% | 12,103 | +8.2% | 0.00% | 0.0% |
| Q4 2022 | $240,189 | +172.9% | 11,182 | +50.0% | 0.00% | 0.0% |
| Q3 2022 | $88,000 | -15.4% | 7,456 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $104,000 | -39.5% | 7,851 | -4.3% | 0.00% | 0.0% |
| Q1 2022 | $172,000 | +0.6% | 8,204 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $171,000 | -32.7% | 8,435 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $254,000 | +66.0% | 8,380 | +58.7% | 0.00% | 0.0% |
| Q2 2021 | $153,000 | -30.1% | 5,280 | +3.9% | 0.00% | 0.0% |
| Q1 2021 | $219,000 | +157.6% | 5,083 | +176.9% | 0.00% | 0.0% |
| Q4 2020 | $85,000 | +6.2% | 1,836 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $80,000 | – | 1,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |